Dinfectome
About:
Dinfectome researches and develops molecular detection technology.
Website: http://www.dinfectome.com
Top Investors: IDG Capital
Description:
Dinfectome researches and develops molecular detection technology. It provides biotechnology solutions to improve testing of various diseases. Dinfectome is based in Nanjing, China.
Total Funding Amount:
200M CNY
Headquarters Location:
Nanjing, Jiangsu, China
Founded Date:
2018-01-01
Founders:
Number of Employees:
101-250
Last Funding Date:
2021-07-27
IPO Status:
Private
Industries:
© 2025 bioDAO.ai